Cite Filings / STLN / 0001079973-25-001045

Feed Companies Filings Check

Sign in

CORRESP

Correspondence Between Filers and SEC Staff

Starling Oncology, Inc. Filed 2025-06-16 Acc 0001079973-25-001045

Documents 1

CORRESP Correspondence Between Filers and SEC Staff , filename1.htm

Around this filing

2025-06-20 4 Director acquired 779,900 shares (conversion)
2025-06-18 EFFECT Notice of Effectiveness
2025-06-16 CORRESP Correspondence Between Filers and SEC Staff
2025-06-16 S-3/A Registration Statement
2025-06-12 UPLOAD SEC-generated Letter
2025-06-09 4 Director sold 750,000 shares at $3.05 ($2,287,500)
2025-05-14 CORRESP Correspondence Between Filers and SEC Staff

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading filename1.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…